XML 19 R3.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated statements of financial position - AUD ($)
Jun. 30, 2023
Jun. 30, 2022
Jul. 01, 2021
Current assets      
Cash and cash equivalents $ 5,241,197 $ 7,361,112 $ 27,587,000
Trade and other receivables 3,899,000 91,000 84,000
Other assets 1,632,000 1,997,000 1,720,000
Total current assets 10,772,000 9,449,000 29,391,000
Non-current assets      
Trade and other receivables 43,000 7,301,000 6,694,000
Intangibles 17,269,000 19,139,000 21,008,000
Total non-current assets 17,312,000 26,440,000 27,702,000
Total assets 28,084,000 35,889,000 57,093,000
Current liabilities      
Trade and other payables 4,329,000 3,759,000 4,933,000
Borrowings 1,796,000 1,841,000 0
Employee benefits 690,000 369,000 229,000
Contingent consideration 750,000 759,000 791,000
Total current liabilities 7,565,000 6,728,000 5,953,000
Non-Current liabilities      
Deferred tax 2,289,000 2,560,000 2,928,000
Employee benefits 59,000 117,000 55,000
Contingent consideration 6,121,000 8,209,000 10,304,000
Total non-current liabilities 8,469,000 10,886,000 13,287,000
Total liabilities 16,034,000 17,614,000 19,240,000
Net assets 12,050,000 18,275,000 37,853,000
Equity      
Contributed equity 97,452,246 84,480,249 80,290,000
Other contributed equity 0 0 464,000
Reserves 3,681,000 2,412,000 1,301,000
Accumulated losses (89,083,000) (68,617,000) (44,202,000)
Equity attributable to the owners of Kazia Therapeutics Limited 12,050,000 18,275,000 37,853,000
Total equity $ 12,050,000 $ 18,275,000 $ 37,853,000